Jeevan Scientific Technology Adjusts Evaluation Amid Mixed Financial Performance and Market Trends
Jeevan Scientific Technology, a microcap in the Pharmaceuticals & Drugs sector, has recently experienced a score adjustment amid mixed financial indicators. In Q3 FY24-25, the company reported a 23.49% increase in net sales and a low Debt to EBITDA ratio, despite facing stock performance challenges over the past year.
Jeevan Scientific Technology, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting a shift in its score. This revision comes amidst a backdrop of mixed financial indicators and market dynamics.In the latest quarter, Q3 FY24-25, Jeevan Scientific Technology reported positive financial performance, with net sales reaching Rs 12.51 crore, marking a growth of 23.49%. Additionally, the company has demonstrated a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.03 times. Over the past three quarters, the company has consistently declared positive results, with a notable increase in profit after tax (PAT) to Rs 0.35 crore.
Despite these positive metrics, the stock has faced challenges, including a consistent underperformance against the benchmark over the last three years and a return of -18.24% in the past year. The technical indicators suggest a bearish trend, with factors such as MACD and Bollinger Bands contributing to this outlook.
Overall, the evaluation adjustment reflects the complexities of Jeevan Scientific Technology's current market position and performance indicators.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
